Abstract
Na+,K+-ATPase distributes ions between the intracellular and extracellular space and is responsible for total-body sodium homeostasis. The activity of this ion pump is regulated by catecholamines and peptide hormones; by the ligand of Na+,K+-ATPase, ouabain; and by direct interaction with cytoskeleton proteins. This review summarizes recent advances in the field of short-term regulation of Na+,K+-ATPase and the implications of these advances for the regulation of blood pressure. Renal Na+,K+-ATPase activity is bidirectionally regulated by natriuretic and antinatriuretic hormones, and a shift in the balance between these forces may lead to salt retention and hypertension. Dopamine plays a key role in this interactive regulation. By inhibiting vascular Na+,K+-ATPase activity, an excess of circulating ouabain may increase calcium concentration in vascular cells and lead to increased vascular contractility. Finally, mutations in cytoskeleton proteins may stimulate renal Na+,K+-ATPase activity by way of protein/protein interaction and lead to salt retention and hypertension. Abnormalities in the systems regulating Na+,K+-ATPase should be explored further in the search for the multiple causes of essential hypertension.
Similar content being viewed by others
References and Recommended Reading
Lingrel JB, Kuntzweiler T: Na+,K(+)-ATPase. J Biol Chem 1994, 269:19659–19662.
Lingrel JB, Croyle ML, Woo AL, et al.: Ligand binding sites of Na,K-ATPase. Acta Physiol Scand Suppl 1998, 643:69–77.
Crambert G, Hasler U, Beggah AT, et al.: Transport and pharmacological properties of nine different human Na,KATPase isozymes. J Biol Chem 2000, 275:1976–1986.
Therien AG, Blostein R: Mechanisms of sodium pump regulation. Am J Physiol 2000, 279:C541-C566. Excellent review on the regulation of Na+,K+-ATPase. Also discusses aspects of long-term regulation that are not covered in the current review.
Bertorello A, Aperia A, Walaas I, et al.: Phosphorylation of the catalytic subunit of Na+,K+-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci U S A 1991, 88:11359–11362.
Fisone G, Cheng S X-J, Nairn AC, et al.: Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K+ATPase and effects of site-directed mutagenesis. J Biol Chem 1994, 269:9368–9373.
Logvinenko NS, Dulubova I, Fedosova N, et al.: Phosphorylation by protein kinase C of serine-23 of the α-1 subunit of rat Na+,K+-ATPase affects its conformational equilibrium. Proc Natl Acad Sci U S A 1996, 93:9132–9137.
Belusa R, Wang Z, Matsubara T, et al.: Mutation of the site of protein kinase C phosphorylation on rat a1 Na+,K+-ATPase alters regulation of intracellular Na+, pH and influences cell shape and adhesiveness. J Biol Chem 1997, 272:20179–20184.
Feschenko MS, Sweadner KJ: Structural basis for species-specific differences in the phosphorylation of Na,K-ATPase by protein kinase C. J Biol Chem 1995, 270:14072–14077.
Cheng XJ, Hoog JO, Nairn AC, et al.: Regulation of rat Na(+)-K(+)-ATPase activity by PKC is modulated by state of phosphorylation of Ser-943 by PKA. Am J Physiol 1997, 273(6 Pt 1):C1981-C1086.
Feschenko MS, Stevenson E, Sweadner KJ: Interaction of protein kinase C and cAMP-dependent pathways in the phosphorylation of the Na,K-ATPase. J Biol Chem 2000, 275:34693–34700.
Chibalin AV, Ogimoto G, Pedemonte CH, et al.: Dopamineinduced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and is responsible for the decreased activity in epithelial cells. J Biol Chem 1999, 274:1920–1927.
Efendiev R, Bertorello AM, Pressley TA, et al.: Simultaneous phosphorylation of Ser11 and Ser 18 in the a-subunit promotes the recruitment of Na(+),K(+)-ATPase molecules to the plasma membrane. Biochemistry 2000, 39:9884–9892.
Gao J, Mathias RT, Cohen IS, et al.: Isoprenaline, Ca2+ and the Na+,K+ pump in guinea-pig ventricular myocytes. J Physiol 1992, 449:689–704.
Cheng SX, Aizman O, Nairn AC, et al.: [Ca2+]i determines the effects of protein kinases A and C on activity of rat renal Na+,K+-ATPase. J Physiol (Lond) 1999, 518(Pt 1):37–46. Demonstrates how the level of intracellular calcium influences the functional effects of Na+,K+-ATPase phosphorylation. Resolves many previous controversies in the field and places further attention on the important crosstalk between Na+,K+-ATPase and calcium.
Szent-Gyorgyi A: Chemical Physiology of Contraction in Body and Heart Muscle. New York: Academic Press; 1953.
Hamlyn JM, Ringel R, Schaeffer J, et al.: A circulating inhibitor of (Na+ +K+)ATPase associated with essential hypertension. Nature 1982, 300:650–652.
Hamlyn JM, Lu ZR, Manunta P, et al.: Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin Exp Hypertens 1998, 20(5-6): 523–533.
Schoner W: Ouabain, a new steroid hormone of adrenal gland and hypothalamus. Exp Clin Endocrinol Diabetes 2000, 108:449–454.
Kometiani P, Li J, Gnudi L, et al.: Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. J Biol Chem 1998, 273:15249–15256. So far the most convincing demonstration that Na+,K+-ATPase is a multifunctional protein and that it may also be a signal transducer that regulates growth and differentiation.
Xie Z, Kometiani P, Liu J, et al.: Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 1999, 274:19323–19328.
Devarajan P, Scaramuzzino DA, Morrow JS: Ankyrin binds two distinct cytoplasmic domains of Na,K-ATPase a subunit. Proc Natl Acad Sci U S A 1994, 91:2965–2969.
Zhang Z, Devarajan P, Dorfman AL, et al.: Structure of the ankyrin-binding domain of a-Na,K-ATPase. J Biol Chem 1998, 273:18681–18684.
Cantiello HF: Changes in actin filament organization regulate Na+,K(+)-ATPase activity. Role of actin phosphorylation. Ann N Y Acad Sci 1997, 834:559–561.
Ferrandi M, Salardi S, Tripodi G, et al.: Evidence for an interaction between adducin and Na+,K+-ATPase: relation to genetic hypertension. Am J Physiol Heart Circ Physiol 1999, 277:H1338-H1349.
Mercer RW, Biemesderfer D, Bliss DP Jr, et al.: Molecular cloning and immunological characterization of the g polypeptide, a small protein associated with the Na,K-ATPase. J Cell Biol 1993, 121:579–586.
Arystarkhova E, Wetzel RK, Asinovski NK, et al.: The gamma subunit modulates Na(+) and K(+) affinity of the renal Na,K-ATPase. J Biol Chem 1999, 274:33183–33185.
Meij IC, Koenderink JB, van Bokhoven H, et al.: Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit. Nat Genet 2000, 26:265–266.
Sweadner KJ, Wetzel RK, Arystarkhova E: Genomic organization of the human FXYD2 gene encoding the g subunit of the Na, K-ATPase. Biochem Biophys Res Commun 2000, 279:196–201.
Aperia A, Bertorello A, Seri I: Dopamine causes inhibition of Na+,K+ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987, 252:F39-F45.
Aperia A: Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000, 62:621–647.
Eklöf A-C, Holtbäck U, Sundelöf M, et al.: Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase. Kidney Int 1997, 52:742–747.
Brismar H, Asghar M, Carey RM, et al.: Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A 1998, 95:5573–5578.
Holtbäck U, Brismar H, DiBona GF, et al.: Receptor recruitment: a mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci U S A 1999, 96:7271–7275. Presents a novel concept for hormonal interaction.
Meister B, Fryckstedt J, Schalling M, et al.: Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells. Proc Natl Acad Sci U S A 1989, 86:8068–8072.
Li D, Belusa R, Nowicki S, et al.: Arachidonic acid metabolic pathways regulating activity of renal Na+-K+-ATPase are age dependent. Am J Physiol Renal Physiol 2000, 278:F823-F829.
Omata K, Abraham NG, Escalante B, et al.: Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol 1992, 262:F8-F16.
Katoh T, Sophasan S, Kurokawa K: Permissive role of dopamine in renal action of ANP in volume-expanded rats. Am J Physiol 1989, 257:F300-F309.
Hedge SS, Chen C-J, Lokhandwala MF: Involvement of endogenous dopamine and DA-1 receptors in the renal effects of atrial natriuretic factor in rats. Clin Exp Hypertens 1991, A13:357–369.
Ibarra F, Aperia A, Svensson L-B, et al.: Bidirectional regulation of Na+,K+-ATPase activity by dopamine and an a-adrenergic agonist. Proc Natl Acad Sci U S A 1993, 90:21–24.
Wang ZQ, Siragy HM, Felder RA, et al.: Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion. Hypertension 1997, 29(1 Pt 2):228–234.
Aperia A, Holtbäck U, Syrén M-L, et al.: Activation/deactivation of renal Na+,K+-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994, 8:436–439.
Aperia A, Fryckstedt J, Holtbäck U, et al.: Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. Kidney Int 1996, 49:1743–1747.
Greengard P, Allen PB, Nairn AC: Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 1999, 23:435–447.
Hussain T, Lokhandwala MF: Renal dopamine receptor function in hypertension. Hypertension 1998, 32:187–197.
Jose PA, Eisner GM, Drago J, et al.: Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 1996, 9:400–405.
Nishi A, Eklöf A-C, Bertorello AM, et al.: Dopamine regulation of renal Na+,K+-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993, 21:767–771.
Sanada H, Jose PA, Hazen-Martin D, et al.: Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999, 33:1036–1042.
Albrecht FE, Drago J, Felder RA, et al.: Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996, 97:2283–2288.
Asico LD, Ladines C, Fuchs S, et al.: Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 1998, 102:493–498.
Tripodi G, Valtorta F, Torielli L, et al.: Hypertension-associated point mutations in the adducin a and b subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996, 97:2815–2822.
Zagato L, Modica R, Florio M, et al.: Genetic mapping of blood pressure quantitative trait loci in Milan hypertensive rats. Hypertension 2000, 36:734–739. Presents clinical evidence that mutation in a cytoskeleton protein that interacts with Na+,K+-ATPase leads to hypertension.
Manunta P, Burnier M, D’Amico M, et al.: Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 1999, 33:694–697.
Blaustein MP: Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int 1996, 49:1748–1753.
Rossoni LV, Cunha V, Franca A, et al.: The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J Cardiovasc Pharmacol 1999, 34:887–892.
Blaustein MP, Juhaszova M, Golovina VA: The cellular mechanism of action of cardiotonic steroids: a new hypothesis. Clin Exp Hypertens 1998, 20(5-6):691–703.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aperia, A. Regulation of sodium/potassium ATPase activity: Impact on salt balance and vascular contractility. Current Science Inc 3, 165–171 (2001). https://doi.org/10.1007/s11906-001-0032-8
Issue Date:
DOI: https://doi.org/10.1007/s11906-001-0032-8